Therefore, we hypothesized that PD-L1 expressed on non-tumor cells in the tumor microenvironment, including bone marrow-derived cells and stromal cells, may also trigger the PD-L1 CCR presented on CAR-T cells to provide costimulatory signal for optimal activation (Fig. 1d). Here, CD274 is linked to neoplasm.